Recruiting Friedreich Ataxia Studies in Iowa City
About Friedreich Ataxia Clinical Trials in Iowa City
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
There are currently 2 friedreich ataxia clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 3,085 participants. Research is being sponsored by Friedreich's Ataxia Research Alliance, Larimar Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Friedreich Ataxia Clinical Trials in Iowa City — FAQ
Are there friedreich ataxia clinical trials in Iowa City?
Yes, there are 2 friedreich ataxia clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What friedreich ataxia treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for friedreich ataxia.
Data updated October 17, 2026 from ClinicalTrials.gov